General
A New Alzheimer's Drug Just Hit a Major Milestone in a Human Clinical Trial
 

A New Alzheimer's Drug Just Hit a Major Milestone in a Human Clinical Trial

Shared by:

 
A new drug that targets toxic amyloid proteins in the brain - one of the main hallmarks of Alzheimer’s disease - has produced such promising results in a small clinical trial, it’s now being assessed in two larger trials involving 3,500 patients.
 
www.sciencealert.com
 
4 Nov 2016 - General
 
A new drug for treatment of Alzheimer's has cleared phase I clinical trials and has shown promising results in slowing down the progression of the disease. And if this drug makes it to the next level it could be the first treatment to enter the market in more than 10 years. Even with so much advanced western medicine, there are so few treatments available fr Alzheimer's disease. We have identified the pathophysiology behind the disease and it seems not very difficult to prevent the prog...
 (Total 115 words)